by Jyoti Madhusoodanan, special to C&EN JANUARY 14, 2019 | APPEARED IN VOLUME 97, ISSUE 2
In The News
Chemical and Engineering News | March 13, 2019
Boston Business Journal | February 19, 2019
by Allison DeAngelis – Life Sciences Reporter, Boston Business Journal Feb 19, 2019, 6:04am EST Could a blood test diagnose Alzheimer's disease up to 16 years before a person begins showing symptoms? The chief executive at Lexington-based Quanterix Corp. believes so.
Forbes | March 05, 2019
by Peter Cohan Plenty of lists have been made to highlight movies with great lessons for executives. Bloomberg even asked business school deans for their favorites and here are their top 30.
WCVB News Boston | February 06, 2019
WCVB's Emily Reimer explores Quanterix' next generation Simoa planar array technology.
NECN | January 25, 2019
An overview of Quanterix’ story, detailing our groundbreaking Simoa technology, the process of measuring biomarkers to detect and advance the treatment of disease, as well as the real world applications of how our technology is impacting how health care is practiced.
GenomeWeb/360dx | January 28, 2019
Jan 24, 2019 | Adam Bonislawski
CNN | January 22, 2019
By Nina Avramova, CNN Tue January 22, 2019 (CNN) A simple blood test could predict if a patient will develop Alzheimer's disease up to 16 years before symptoms begin, a new study finds.
Genome Web | January 10, 2019
Jan 10, 2019 | Monica Heger
January 09, 2019
CEO Kevin Hrusovsky wows a packed audience with Quanterix' vision and progress towards transforming healthcare at the 2019 J.P. Morgan Health Conference in San Francisco.